- Ownership
-
Athira Pharma, Inc. Insider Trading
* In original currency USD
Loading Data
Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price | Total Amount |
---|---|---|---|---|---|---|---|---|
Monday, June 30th, 2025 | CHURCH KEVIN | officer: CHIEF SCIENTIFIC OFFICER | 177,427 | M-Exempt | A | 36,666 | 0.00 USD | 0 USD |
Tuesday, July 1st, 2025 | CHURCH KEVIN | officer: CHIEF SCIENTIFIC OFFICER | 168,901 | S-Sale | D | 8,526 | 0.29 USD | 2,502 USD |
Monday, May 19th, 2025 | CHURCH KEVIN | officer: CHIEF SCIENTIFIC OFFICER | 140,761 | A-Award | A | 10,000 | 0.23 USD | 2,312 USD |
Monday, June 30th, 2025 | CHURCH KEVIN | officer: CHIEF SCIENTIFIC OFFICER | 36,667 | M-Exempt | D | 36,666 | 0.00 USD | 0 USD |
Monday, June 30th, 2025 | Litton Mark James | director, officer: President and CEO | 350,925 | M-Exempt | A | 108,334 | 0.00 USD | 0 USD |
Tuesday, July 1st, 2025 | Litton Mark James | director, officer: President and CEO | 325,802 | S-Sale | D | 25,123 | 0.29 USD | 7,374 USD |
Monday, June 30th, 2025 | Litton Mark James | director, officer: President and CEO | 108,333 | M-Exempt | D | 108,334 | 0.00 USD | 0 USD |
Monday, June 30th, 2025 | San Martin Javier | officer: CHIEF MEDICAL OFFICER | 82,507 | M-Exempt | A | 46,666 | 0.00 USD | 0 USD |
Tuesday, July 1st, 2025 | San Martin Javier | officer: CHIEF MEDICAL OFFICER | 71,665 | S-Sale | D | 10,842 | 0.29 USD | 3,182 USD |
Monday, June 30th, 2025 | San Martin Javier | officer: CHIEF MEDICAL OFFICER | 46,667 | M-Exempt | D | 46,666 | 0.00 USD | 0 USD |
Monday, June 30th, 2025 | Worthington Mark | officer: General Counsel and CCO | 120,401 | M-Exempt | A | 36,666 | 0.00 USD | 0 USD |
Tuesday, July 1st, 2025 | Worthington Mark | officer: General Counsel and CCO | 111,875 | S-Sale | D | 8,526 | 0.29 USD | 2,502 USD |
Monday, June 30th, 2025 | Worthington Mark | officer: General Counsel and CCO | 36,667 | M-Exempt | D | 36,666 | 0.00 USD | 0 USD |
Monday, June 30th, 2025 | Renninger Robert | officer: SVP, Finance and Accounting | 112,083 | M-Exempt | A | 12,359 | 0.00 USD | 0 USD |
Tuesday, July 1st, 2025 | Renninger Robert | officer: SVP, Finance and Accounting | 109,186 | S-Sale | D | 2,897 | 0.29 USD | 850 USD |
Monday, May 19th, 2025 | Renninger Robert | officer: SVP, Finance and Accounting | 99,724 | A-Award | A | 10,000 | 0.23 USD | 2,312 USD |
Monday, June 30th, 2025 | Renninger Robert | officer: SVP, Finance and Accounting | 12,359 | M-Exempt | D | 12,359 | 0.00 USD | 0 USD |
Friday, May 30th, 2025 | FLUKE JOHN M JR | director | 20,900 | A-Award | A | 20,900 | 0.31 USD | 6,531 USD |
Friday, May 30th, 2025 | Panzara Michael A. | director | 20,900 | A-Award | A | 20,900 | 0.31 USD | 6,531 USD |
Friday, May 30th, 2025 | Romano Kelly A | director | 20,900 | A-Award | A | 20,900 | 0.31 USD | 6,531 USD |
Friday, May 30th, 2025 | EDELMAN JOSEPH | director | 20,900 | A-Award | A | 20,900 | 0.31 USD | 6,531 USD |
Friday, May 30th, 2025 | JOHNSON JAMES A | director | 20,900 | A-Award | A | 20,900 | 0.31 USD | 6,531 USD |
Friday, May 30th, 2025 | Kosacz Barbara | director | 20,900 | A-Award | A | 20,900 | 0.31 USD | 6,531 USD |
Friday, May 30th, 2025 | PICKERING GRANT | director | 20,900 | A-Award | A | 20,900 | 0.31 USD | 6,531 USD |
Monday, March 3rd, 2025 | Renninger Robert | officer: SVP, Finance and Accounting | 73,350 | A-Award | A | 73,350 | 0.38 USD | 27,594 USD |
Monday, March 3rd, 2025 | Renninger Robert | officer: SVP, Finance and Accounting | 58,500 | A-Award | A | 58,500 | 0.38 USD | 22,008 USD |
Monday, March 3rd, 2025 | Renninger Robert | officer: SVP, Finance and Accounting | 39,000 | A-Award | A | 39,000 | 0.00 USD | 0 USD |
Monday, March 3rd, 2025 | CHURCH KEVIN | officer: CHIEF SCIENTIFIC OFFICER | 87,845 | A-Award | A | 87,845 | 0.38 USD | 33,047 USD |
Monday, March 3rd, 2025 | CHURCH KEVIN | officer: CHIEF SCIENTIFIC OFFICER | 58,563 | A-Award | A | 58,563 | 0.00 USD | 0 USD |
Monday, March 3rd, 2025 | Litton Mark James | director, officer: President and CEO | 333,815 | A-Award | A | 333,815 | 0.38 USD | 125,581 USD |
Monday, March 3rd, 2025 | Litton Mark James | director, officer: President and CEO | 222,543 | A-Award | A | 222,543 | 0.00 USD | 0 USD |
Monday, March 3rd, 2025 | San Martin Javier | officer: CHIEF MEDICAL OFFICER | 111,270 | A-Award | A | 111,270 | 0.38 USD | 41,860 USD |
Monday, March 3rd, 2025 | San Martin Javier | officer: CHIEF MEDICAL OFFICER | 74,180 | A-Award | A | 74,180 | 0.00 USD | 0 USD |
Monday, March 3rd, 2025 | Worthington Mark | officer: General Counsel and CCO | 85,895 | A-Award | A | 85,895 | 0.38 USD | 32,314 USD |
Monday, March 3rd, 2025 | Worthington Mark | officer: General Counsel and CCO | 57,263 | A-Award | A | 57,263 | 0.00 USD | 0 USD |
Tuesday, December 31st, 2024 | San Martin Javier | officer: CHIEF MEDICAL OFFICER | 93,333 | M-Exempt | D | 46,667 | 0.00 USD | 0 USD |
Tuesday, December 31st, 2024 | San Martin Javier | officer: CHIEF MEDICAL OFFICER | 46,667 | M-Exempt | A | 46,667 | 0.00 USD | 0 USD |
Thursday, January 2nd, 2025 | San Martin Javier | officer: CHIEF MEDICAL OFFICER | 35,841 | S-Sale | D | 10,826 | 0.56 USD | 6,083 USD |
Tuesday, December 31st, 2024 | Litton Mark James | director, officer: President and CEO | 267,698 | M-Exempt | A | 108,333 | 0.00 USD | 0 USD |
Thursday, January 2nd, 2025 | Litton Mark James | director, officer: President and CEO | 242,591 | S-Sale | D | 25,107 | 0.56 USD | 14,108 USD |
Tuesday, December 31st, 2024 | Litton Mark James | director, officer: President and CEO | 216,667 | M-Exempt | D | 108,333 | 0.00 USD | 0 USD |
Tuesday, December 31st, 2024 | CHURCH KEVIN | officer: CHIEF SCIENTIFIC OFFICER | 139,271 | M-Exempt | A | 36,667 | 0.00 USD | 0 USD |
Thursday, January 2nd, 2025 | CHURCH KEVIN | officer: CHIEF SCIENTIFIC OFFICER | 130,761 | S-Sale | D | 8,510 | 0.56 USD | 4,782 USD |
Monday, November 18th, 2024 | CHURCH KEVIN | officer: CHIEF SCIENTIFIC OFFICER | 102,604 | A-Award | A | 9,920 | 0.55 USD | 5,456 USD |
Tuesday, December 31st, 2024 | CHURCH KEVIN | officer: CHIEF SCIENTIFIC OFFICER | 73,333 | M-Exempt | D | 36,667 | 0.00 USD | 0 USD |
Tuesday, December 31st, 2024 | Renninger Robert | officer: VP of Finance | 92,605 | M-Exempt | A | 12,359 | 0.00 USD | 0 USD |
Thursday, January 2nd, 2025 | Renninger Robert | officer: VP of Finance | 89,724 | S-Sale | D | 2,881 | 0.56 USD | 1,619 USD |
Monday, November 18th, 2024 | Renninger Robert | officer: VP of Finance | 80,246 | A-Award | A | 3,651 | 0.55 USD | 2,008 USD |
Tuesday, December 31st, 2024 | Renninger Robert | officer: VP of Finance | 24,718 | M-Exempt | D | 12,359 | 0.00 USD | 0 USD |
Tuesday, December 31st, 2024 | Worthington Mark | officer: General Counsel and CCO | 92,245 | M-Exempt | A | 36,667 | 0.00 USD | 0 USD |
Thursday, January 2nd, 2025 | Worthington Mark | officer: General Counsel and CCO | 83,735 | S-Sale | D | 8,510 | 0.56 USD | 4,782 USD |
Tuesday, December 31st, 2024 | Worthington Mark | officer: General Counsel and CCO | 73,333 | M-Exempt | D | 36,667 | 0.00 USD | 0 USD |
Monday, November 18th, 2024 | Worthington Mark | officer: General Counsel and CCO | 55,578 | A-Award | A | 3,651 | 0.55 USD | 2,008 USD |
Thursday, October 3rd, 2024 | Litton Mark James | director, officer: President and CEO | 325,000 | A-Award | A | 325,000 | 0.43 USD | 138,353 USD |
Tuesday, October 1st, 2024 | Renninger Robert | officer: VP of Finance | 37,077 | A-Award | A | 37,077 | 0.00 USD | 0 USD |
Tuesday, October 1st, 2024 | Renninger Robert | officer: VP of Finance | 37,077 | A-Award | A | 37,077 | 0.45 USD | 16,681 USD |
Tuesday, October 1st, 2024 | San Martin Javier | officer: CHIEF MEDICAL OFFICER | 140,000 | A-Award | A | 140,000 | 0.00 USD | 0 USD |
Tuesday, October 1st, 2024 | San Martin Javier | officer: CHIEF MEDICAL OFFICER | 140,000 | A-Award | A | 140,000 | 0.45 USD | 62,986 USD |
Tuesday, October 1st, 2024 | CHURCH KEVIN | officer: CHIEF SCIENTIFIC OFFICER | 110,000 | A-Award | A | 110,000 | 0.00 USD | 0 USD |
Tuesday, October 1st, 2024 | CHURCH KEVIN | officer: CHIEF SCIENTIFIC OFFICER | 110,000 | A-Award | A | 110,000 | 0.45 USD | 49,489 USD |
Tuesday, October 1st, 2024 | Worthington Mark | officer: General Counsel and CCO | 110,000 | A-Award | A | 110,000 | 0.00 USD | 0 USD |
Tuesday, October 1st, 2024 | Worthington Mark | officer: General Counsel and CCO | 110,000 | A-Award | A | 110,000 | 0.45 USD | 49,489 USD |
Thursday, October 3rd, 2024 | Litton Mark James | director, officer: President and CEO | 325,000 | A-Award | A | 325,000 | 0.00 USD | 0 USD |
Thursday, October 3rd, 2024 | Litton Mark James | director, officer: President and CEO | 325,000 | A-Award | A | 325,000 | 0.45 USD | 146,218 USD |
Tuesday, October 1st, 2024 | Renninger Robert | officer: VP of Finance | 76,595 | 0 | 0.00 USD | 0 USD | ||
Tuesday, October 1st, 2024 | Renninger Robert | officer: VP of Finance | 0 | 18,915 | 17.00 USD | 321,555 USD | ||
Tuesday, October 1st, 2024 | Renninger Robert | officer: VP of Finance | 0 | 1,085 | 22.22 USD | 24,109 USD | ||
Tuesday, October 1st, 2024 | Renninger Robert | officer: VP of Finance | 0 | 10,000 | 21.15 USD | 211,500 USD | ||
Tuesday, October 1st, 2024 | Renninger Robert | officer: VP of Finance | 0 | 13,000 | 12.38 USD | 160,940 USD | ||
Tuesday, October 1st, 2024 | Renninger Robert | officer: VP of Finance | 0 | 40,600 | 10.64 USD | 431,984 USD | ||
Tuesday, October 1st, 2024 | Renninger Robert | officer: VP of Finance | 0 | 56,750 | 3.37 USD | 191,248 USD | ||
Tuesday, October 1st, 2024 | Renninger Robert | officer: VP of Finance | 0 | 74,154 | 3.26 USD | 241,742 USD | ||
Tuesday, September 3rd, 2024 | Gengos Andrew | officer: CFO and Chief Business Officer | 98,804 | A-Award | A | 5,000 | 0.00 USD | 0 USD |
Thursday, September 5th, 2024 | Gengos Andrew | officer: CFO and Chief Business Officer | 97,532 | S-Sale | D | 1,272 | 0.57 USD | 720 USD |
Monday, May 20th, 2024 | Gengos Andrew | officer: CFO and Chief Business Officer | 93,804 | A-Award | A | 10,000 | 1.34 USD | 13,400 USD |
Tuesday, September 3rd, 2024 | Lenington Rachel | officer: COO and CDO | 23,395 | A-Award | A | 10,000 | 0.00 USD | 0 USD |
Thursday, September 5th, 2024 | Lenington Rachel | officer: COO and CDO | 20,870 | S-Sale | D | 2,525 | 0.57 USD | 1,429 USD |
Tuesday, September 3rd, 2024 | CHURCH KEVIN | officer: CHIEF SCIENTIFIC OFFICER | 95,209 | A-Award | A | 10,000 | 0.00 USD | 0 USD |
Thursday, September 5th, 2024 | CHURCH KEVIN | officer: CHIEF SCIENTIFIC OFFICER | 92,684 | S-Sale | D | 2,525 | 0.57 USD | 1,429 USD |
Monday, May 20th, 2024 | CHURCH KEVIN | officer: CHIEF SCIENTIFIC OFFICER | 85,209 | A-Award | A | 4,953 | 1.34 USD | 6,637 USD |
Tuesday, September 3rd, 2024 | Worthington Mark | officer: GENERAL COUNSEL | 54,452 | A-Award | A | 10,000 | 0.00 USD | 0 USD |
Thursday, September 5th, 2024 | Worthington Mark | officer: GENERAL COUNSEL | 51,927 | S-Sale | D | 2,525 | 0.57 USD | 1,429 USD |
Monday, May 20th, 2024 | Worthington Mark | officer: GENERAL COUNSEL | 44,452 | A-Award | A | 10,000 | 1.34 USD | 13,400 USD |
Tuesday, September 3rd, 2024 | Litton Mark James | director, officer: President and CEO | 164,397 | A-Award | A | 20,000 | 0.00 USD | 0 USD |
Thursday, September 5th, 2024 | Litton Mark James | director, officer: President and CEO | 159,365 | S-Sale | D | 5,032 | 0.57 USD | 2,848 USD |
Monday, June 24th, 2024 | Romano Kelly A | director | 80,715 | P-Purchase | A | 27,400 | 2.42 USD | 66,179 USD |
Friday, June 21st, 2024 | Romano Kelly A | director | 53,315 | P-Purchase | A | 15,000 | 2.26 USD | 33,872 USD |
Friday, May 24th, 2024 | Romano Kelly A | director | 20,900 | A-Award | A | 20,900 | 2.64 USD | 55,176 USD |
Friday, May 24th, 2024 | EDELMAN JOSEPH | director | 20,900 | A-Award | A | 20,900 | 2.64 USD | 55,176 USD |
Friday, May 24th, 2024 | JOHNSON JAMES A | director | 20,900 | A-Award | A | 20,900 | 2.64 USD | 55,176 USD |
Friday, May 24th, 2024 | Kosacz Barbara | director | 20,900 | A-Award | A | 20,900 | 2.64 USD | 55,176 USD |
Friday, May 24th, 2024 | Panzara Michael A. | director | 20,900 | A-Award | A | 20,900 | 2.64 USD | 55,176 USD |
Friday, May 24th, 2024 | PICKERING GRANT | director | 20,900 | A-Award | A | 20,900 | 2.64 USD | 55,176 USD |
Friday, May 24th, 2024 | FLUKE JOHN M JR | director | 20,900 | A-Award | A | 20,900 | 2.64 USD | 55,176 USD |
Monday, April 15th, 2024 | San Martin Javier | officer: CHIEF MEDICAL OFFICER | 400,000 | A-Award | A | 400,000 | 2.06 USD | 824,000 USD |
Monday, April 15th, 2024 | San Martin Javier | 0 | 0 | 0.00 USD | 0 USD | |||
Thursday, February 15th, 2024 | Litton Mark James | director, officer: CEO | 650,000 | A-Award | A | 650,000 | 3.66 USD | 2,379,000 USD |
Wednesday, February 14th, 2024 | Worthington Mark | officer: GENERAL COUNSEL | 220,000 | A-Award | A | 220,000 | 3.26 USD | 717,200 USD |
Wednesday, February 14th, 2024 | CHURCH KEVIN | officer: CHIEF SCIENTIFIC OFFICER | 220,000 | A-Award | A | 220,000 | 3.26 USD | 717,200 USD |
Wednesday, February 14th, 2024 | Gengos Andrew | officer: CFO AND CHIEF BUSINESS OFFICER | 280,000 | A-Award | A | 280,000 | 3.26 USD | 912,800 USD |